Category: MediWound
-
MediWound raises $25m, acquisition still possible
•
Israeli biopharmaceutical company Midwind MDWD (Nasdaq: MDWD), a developer of products for the treatment of burns and wounds, announced that it has raised $25 million in a private placement led by Swedish company Mölnlycke Health Care, a global leader in wound care. Over the past few weeks, MediWound’s stock price…